| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
American Society of Hematology (ASH) 61st Annual Meeting: Orlando, FL, USA, 6–10 December 2019
|
Chopra, Martin
|
|
|
15 |
1 |
p. 1-6
|
article
|
| 2 |
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
|
Faloppi, Luca
|
|
|
15 |
1 |
p. 115-126
|
article
|
| 3 |
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study
|
Faloppi, Luca
|
|
|
15 |
1 |
p. 115-126
|
article
|
| 4 |
Association Between Glutathione-S-Transferase Gene Polymorphisms and Responses to Tyrosine Kinase Inhibitor Treatment in Patients with Chronic Myeloid Leukemia: A Meta-analysis
|
Lee, Nari
|
|
|
15 |
1 |
p. 47-54
|
article
|
| 5 |
Brain Penetration of Lorlatinib: Cumulative Incidences of CNS and Non-CNS Progression with Lorlatinib in Patients with Previously Treated ALK-Positive Non-Small-Cell Lung Cancer
|
Bauer, Todd M.
|
|
|
15 |
1 |
p. 55-65
|
article
|
| 6 |
BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta-Analysis
|
Teixeira, Lorena Alves
|
|
|
15 |
1 |
p. 37-46
|
article
|
| 7 |
BRCA1 Expression by Immunohistochemistry and Prognosis in Ovarian Cancer: A Systematic Review and Meta-Analysis
|
Teixeira, Lorena Alves
|
|
|
15 |
1 |
p. 37-46
|
article
|
| 8 |
c-MET as a Potential Resistance Mechanism to Everolimus in Breast Cancer: From a Case Report to Patient Cohort Analysis
|
Van den Bossche, Valentin
|
|
|
15 |
1 |
p. 139-146
|
article
|
| 9 |
Genetic Profiling of Advanced Melanoma: Candidate Mutations for Predicting Sensitivity and Resistance to Targeted Therapy
|
Olbryt, Magdalena
|
|
|
15 |
1 |
p. 101-113
|
article
|
| 10 |
High Tumor Mutation Burden and Other Immunotherapy Response Predictors in Breast Cancers: Associations and Therapeutic Opportunities
|
Voutsadakis, Ioannis A.
|
|
|
15 |
1 |
p. 127-138
|
article
|
| 11 |
Immune Checkpoint Inhibition in Colorectal Cancer: Microsatellite Instability and Beyond
|
Cohen, Romain
|
|
|
15 |
1 |
p. 11-24
|
article
|
| 12 |
Immune Checkpoint Inhibitor-Induced Pancreatic Injury: Imaging Findings and Literature Review
|
Porcu, Michele
|
|
|
15 |
1 |
p. 25-35
|
article
|
| 13 |
Pemetrexed/Erlotinib as a Salvage Treatment in Patients with High EGFR-Expressing Metastatic Colorectal Cancer Following Failure of Standard Chemotherapy: A Phase II Single-Arm Prospective Study
|
Kim, Seung Tae
|
|
|
15 |
1 |
p. 67-73
|
article
|
| 14 |
Phase I Study of Irinotecan/5-Fluorouracil/Leucovorin (FOLFIRI) with Sunitinib for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
|
Mukherjee, Sarbajit
|
|
|
15 |
1 |
p. 85-92
|
article
|
| 15 |
Safety, Pharmacokinetics, and Clinical Activity of Adavosertib in Combination with Chemotherapy in Asian Patients with Advanced Solid Tumors: Phase Ib Study
|
Kato, Hidenori
|
|
|
15 |
1 |
p. 75-84
|
article
|
| 16 |
2019 San Antonio Breast Cancer Symposium: San Antonio, TX, USA, 10–14 December 2019
|
Chopra, Martin
|
|
|
15 |
1 |
p. 7-9
|
article
|
| 17 |
Tumor Mutation Burden as a Potential Biomarker for PD-1/PD-L1 Inhibition in Advanced Non-small Cell Lung Cancer
|
Huang, Di
|
|
|
15 |
1 |
p. 93-100
|
article
|
Journal description